Douglas E. Drachman, MD, MSCAI
Director of Education and Director of Interventional Cardiology Fellowship Program
Massachusetts General Hospital
Boston, Massachusetts, United States
Disclosure(s): Abiomed;: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing)
Behnam N. Tehrani, MD
System Associate Director for Interventional Cardiology and Executive Director of Cardiac Cath Labs
Inova Health System
Fairfax, Virginia, United States
Disclosure(s): Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); ReCor: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Joe Aoun, MD
Interventional Cardiology and Structural Heart Disease
Houston Methodist DeBakey Heart & Vascular Center
Disclosure(s): No financial relationships to disclose
Nicolas M. Van Mieghem, MD, PhD, FESC, FACC
Professor and Clinical Director of Interventional cardiology
Thoraxcenter
Rotterdam, Zuid-Holland, Netherlands
Disclosure information not submitted.
Jeremiah P. Depta, MD, MPHS, FACC, FSCAI
Director, Advanced Valvular and StructuralHheart Disease Program
Rochester General Hospital
Webster, New York, United States
Disclosure information not submitted.
Gary Roubin, MD
Chair CREST2 Trial Interventional Management Committee
Disclosure information not submitted.
Brett Wanamaker, MD
Clinical Assistant Professor
University of Michigan
Ann Arbor, Michigan, United States
Disclosure information not submitted.
Anjili Srivastava, DO, FACC
Cardiologist, Clinical Assistant Professor
NYU Langone Hospital Long Island
Disclosure information not submitted.
Vivek Gupta, MD
Disclosure information not submitted.
Luis Guzman, MD, FACC, MSCAI
Medical Director, Cardiac Cath Lab
Mary Washington Hospital
Richmond, Virginia, United States
Disclosure(s): No financial relationships to disclose